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ABSTRACT
Background. Snakes belonging to the Bothrops genus are vastly distributed in Central
and South America and are responsible for most cases of reported snake bites in Latin
America. The clinical manifestations of the envenomation caused by this genus are
due to three major activities—proteolytic, hemorrhagic and coagulant—mediated by
metalloproteinases, serine proteinases, phospholipases A2 and other toxic compounds
present in snake venom. Interestingly, it was observed that snakes are resistant to the
toxic effects of its own and other snake’s venoms. This natural immunity may occur
due the absence of toxin target or the presence of molecules in the snake plasma able
to neutralize such toxins.
Methods. In order to identify anti-venom molecules, we construct a cDNA library
from the liver of B. jararaca snakes. Moreover, we analyzed the expression profile
of four molecules—the already known anti-hemorrhagic factor Bj46a, one gamma-
phospholipase A2 inhibitor, one inter-alpha inhibitor and one C1 plasma protease
inhibitor—in the liver of juvenile and adult snakes by qPCR.
Results. The results revealed a 30-fold increase of gamma-phospholipase A2 inhibitor
and a minor increase of the inter-alpha inhibitor (5-fold) and of the C1 inhibitor (3-
fold) in adults. However, the Bj46a factor seems to be equally transcribed in adults and
juveniles.
Discussion. The results suggest the up-regulation of different inhibitors observed in the
adult snakesmight be a physiological adaptation to the recurrent contact with their own
and even other snake’s venoms throughout its lifespan. This is the first comparative
analysis of ontogenetic variation of expression profiles of plasmatic proteins with
potential anti-venom activities of the venomous snake B. jararaca. Furthermore, the
present data contributes to the understanding of the natural resistance described in
these snakes.
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INTRODUCTION
The genus Bothrops is widely distributed in Central and South America, being the
most common genus reported in ophidian accidents (Cidade et al., 2006). In Brazil,
the species Bothrops jararaca (B. jararaca) accounts for the majority of the 30,000 cases of
envenomation registered annually (Ministério da Saúde, 2016), due to its abundance and
broad geographical distribution.
Clinical manifestations of bothropic envenomation are due to the following venom
activities: (1) proteolytic, resulting in inflammatory edema at the bite site; (2) hemorrhagic,
related to endothelial damage and systemic bleeding; (3) coagulant, responsible for the
consumption of coagulation factors and consequent homeostasis disruption; and (4)
myonecrotic, related to permanent tissue loss, disability and amputation (Rosenfeld,
1971). These activities are mediated by a number of venom components, such as
metalloproteinases, serine proteinases, phospholipases A2 (PLA2s), L-amino acid oxidases
(LAAOs) and other toxic compounds (Fox et al., 2006;Zelanis et al., 2010). The quantitative
and qualitative composition of toxins present in snake venomsmay vary according to several
factors, such as ontogenetic development (Zelanis et al., 2010), seasonal period (Williams &
White, 1992), gender (Menezes et al., 2006), diet (Gibbs & Mackessy, 2009) and geographical
distribution (Alape-Giron et al., 2008).
Another intriguing feature of the physiology of snakes is the ‘‘natural immunity’’ towards
the toxicity of their own venom and other snake venoms. This resistancemay be a result of a
mutation in the gene encoding the target of the venom toxin, rendering the target insensitive
(Burden, Hartzell & Yoshikami, 1975; Ohana et al., 1991) and/or due to the presence of
proteins that neutralize venom components in the blood of resistant animals (Clark &
Voris, 1969; Omori-Satoh, 1977; Omori-Satoh et al., 1972; Straight, Glenn & Snyder, 1976).
This inter- and intra-species resistibility makes snake plasma an interesting and rich source
of bioactive compounds, since it can be explored for the isolation of proteins that can
neutralize the toxic components of snake venoms and can contribute to the development
of new approaches for the treatment of ophidic accidents (De Morais-Zani et al., 2013;
Lizano, Domont & Perales, 2003).
It is believed that studies on the natural resistibility of snakes began with Fontana (1781)
who stated that ‘‘the venomof the viper is not venomous to its species’’, more than 230 years
ago. Eighty years after this pioneer report, Guyon (1861) discovered that the natural immu-
nity is not species-specific. Since the observations made by Fontana (1781), a number of
‘‘plasma factors’’ have been identified, isolated and characterized, not only from venomous
and non-venomous snakes (Thwin et al., 2000) but also from different animals (Fortes-
Dias, 2002; Omori-Satoh, Yamakawa & Mebs, 2000; Thwin & Gopalakrishnakone, 1998).
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In this context, Nahas et al. (1973) were the first to identify the presence of a natural
inhibitor in the plasma of B. jararaca in 1973. Later,Nahas et al. (1983) have also described
the ‘‘inactivating effect’’ of B. jararaca plasma upon the coagulant activity of venom from 27
different snake species. Several inhibitors have already been identified in B. jararaca plasma
and serum. The first molecule isolated from the plasma of this species, to our knowledge,
was described by Tanizaki et al. (1991) and has the ability to inhibit the hemorrhagic
and caseinolytic activity of B. jararaca whole venom. Further, this molecule was reported
to also inhibit the venom pro-coagulant activity and lethality (De Oliveira & Tanizaki,
1992). Besides, an anti-hemorrhagic factor, Bj46a, a potent inhibitor of metalloproteinases
and venom hemorrhagic activity, was also purified from B. jararaca serum (Valente et
al., 2001). In addition, some PLA2s inhibitors (PLIs) are identified in B. jararaca plasma
through proteomic analysis (2D SDS-PAGE and mass spectrometry) (De Morais-Zani et
al., 2013). Interestingly, a comparative study of the plasma composition of juvenile and
adult B. jararaca snakes showed that the inhibitors aforementioned (Bj46a and PLIs) might
be present at different levels during ontogenetic development and that this variability can
be related to the ontogenetic shift described in its venom (De Morais-Zani et al., 2013).
Although there is an increasing interest in the natural resistance of snakes against
venom toxins, the knowledge about snake plasma constitution is still sparse. Therefore,
we constructed a liver cDNA library from B. jararaca snakes and compared the expression
profile of possible anti-venom molecules between adults and juvenile snakes. The results
described herein can open perspectives to the design of new molecules for therapeutic and




Experimental protocols using animals have been conducted in agreement with the Ethical
Principles in Animal Research adopted by the Brazilian College of Animal Experimentation
and were approved by the Ethical Committee for Animal Research of Butantan Institute
(CEUAIB) under registry No. 794/11 and No. 931/12.
B. jararaca liver collection
B. jararaca specimens were obtained from Herpetology Laboratory of Butantan Institute
(São Paulo—Brazil). Eight females were used, five adults and three juveniles, all from
São Paulo State, Brazil. Snakes were euthanized by intracoelomic administration of
thiopental (90 mg kg−1) and lidocaine hydrochloride (5 mg kg−1). The livers were
immediately dissected and stored in liquid nitrogen for cDNA library construction. For
qPCR experiments, livers were stored in Trizol (Invitrogen, Carlsbad, CA, USA) and kept
in −80 ◦C until use.
cDNA library construction and sequencing
The mRNA was isolated from the liver of two adult B. jararaca snakes using the RNAeasy
Mini Kit (Qiagen, Hilden, Germany). Thereafter the cDNA library was constructed
Gomes et al. (2017), PeerJ, DOI 10.7717/peerj.3203 3/19
using the SMART cDNA Library Construction Kit (Clontech, Mountain View, CA, USA)
according to manufacturer’s instructions. The E. coli BM 25.8 strain was inoculated in 2mL
of LBmedium and incubated at 31 ◦C until the OD600 reached 1.3, followed by the addition
of MgCl2 (10 mM) and the amplified cDNA library. Infected bacterial cells were spread
on LB plates containing ampicillin and growth overnight at 31 ◦C. Random isolate clones
were selected and used for mini plasmid preparation, in which 200 ng of each plasmid were
combined with 10 pmol of LD-5′ primer (5′–CTCGGGAAGCGCGCCATTGTGTTGGT
–3′) and BigDye reagent (Applied Biosystems, Foster City, CA, USA) in a final volume of
10 µL. Reactions were submitted to 36 cycles of 96 ◦C –10 s, 50 ◦C –10 s and 60 ◦C –4 min,
followed by precipitation with ethanol and sodium acetate buffer. DNA sequencing was
carried on an ABI 3130 sequencer (Applied Biosystems, Foster City, CA, USA) as described
by Buarque et al. (2013).
Bioinformatics analysis
Bioinformatics analysis was performed as previously described (Karim, Singh & Ribeiro,
2011). The software was written and provided by Dr. José Marcos Ribeiro (NIAID –NIH)
in Visual Basic 6.0 (Microsoft). The functional annotation of CDS was performed through
Blastn and Blastx (Altschul et al., 1990) against several databases (non-redundant protein,
refseq-invertebrate, refseq-protozoa, refseq-vertebrate from NCBI and the custom made
LEPIDOSAURIA database). The functionally annotated sequences were plotted in an excel
spreadsheet Data S1.
Quantitative PCR (qPCR)
Quantitative PCR was performed using three biological samples for each group (juveniles
and adults). Total RNAwas extracted from the liver of adults and juvenilesB. jararaca snakes
using Trizol (Invitrogen, Carlsbad, CA, USA) and quantified using NanoVue equipment
(GE Healthcare). Total RNA was treated with one unit of DNase (Fermentas, Waltham,
MA, USA) for 1 h at 37 ◦ C. Reactions were stopped by adding EDTA and heating for 10min
at 65 ◦C. cDNA synthesis was performed using the ImProm-IITM Reverse Transcription
System (Promega, Madison, WI, USA) following the manufacturer’s guidelines and
qPCR was performed according Livak & Schmittgen (2001), using the SYBR
R©
Green PCR
Master Mix (Applied Biosystems, Foster City, CA, USA) in a 7500 Real-Time PCR System
(Applied Biosystems, Foster City, CA, USA). The qPCR reaction was performed using: 1 µL
of 10X diluted cDNA, 6 µL of SYBR R© Green and 150 nM of each specific-primers: Bj46a
gene (Bj46a forward and Bj46a reverse), γ-PLI gene (γ-PLI forward and γ-PLI reverse),
inter-alpha inhibitor (inter-alpha inhibitor forward and inter-alpha inhibitor reverse) and
plasma protease C1 inhibitor-like (C1- forward and C1- reverse), in a 12 µL final volume.
Primers sequences are listed in Data S2. β-actin gene was used as the internal control. The
PCR program comprised 40 cycles at 94 ◦C (15 s) and 60 ◦C (1min), followed bymelt curve
generation. Melt curves were analyzed to check the specificity of amplification. Reactions
were performed in triplicate (for each biological sample) and all values are represented as
the mean ± standard deviation. An unpaired t test was conducted for statistical analysis,
and a significant difference was accepted at p< 0.05.
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Figure 1 Expression analysis of plasmatic inhibitors from juvenile and adult B. jararaca snakes. The
abundance expression of (A) BJ46a-like (Bj429), (B) γ- phospholipase A2 inhibitor (Bj405), (C) inter-
alpha-trypsin inhibitor (Bj203) and (D) plasma protease C1-inhibitor (Bj84). Error bars represent the
standard deviation of the mean from three independent experiments (n = 3). Statistical analysis was car-




Transcripts encondig to metalloprotease inhibitors were found in our cDNA library
of B. jararaca liver Data S1, including the anti-hemorrhagic factor BJ46a, which presents
inhibitory activity against venom metalloproteases. Quantitative analyses obtained by
qPCR using specific primers for BJ46a showed no significant differences between juvenile
and adult B. jararaca snakes (Fig. 1A). The amino acid sequence deduced from our cDNA
library (amino acids residues 137–345) was aligned against similar proteins described in
other snake species (Fig. 2) and reinforces the similarity among several related-molecules
described in different Viperidae snakes. However, it is important to note that the partial
sequence of this transcript contains specific amino acid residues related to BJ46a (an anti-
hemorrhagic factor from B. jararaca) and HLP-B (a snake fetuin with no anti-hemorrhagic
activity from Gloydius brevicaudus), as well as exclusive amino acid residues Data S3.
Therefore, the molecule described herein is referred as BJ46a-like.
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Figure 2 Multiple alignments of amino acid sequences of Bj46a-like (Bj429) with similar sequences de-
scribed in different species of snakes. The sequences used are from Bothrops jararaca (sp|Q9DGI0.1), Pro-
tobothrops mucrosquamatus (XP_015681073.1), Protobothrops flavoviridis (sp|P29695.2), Gloydius brevi-
caudus (sp|Q5KQS2.1) and Gloydius blomhoffii (sp|Q5KQS1.1). Identical residues are black boxed.
Gamma phospholipase A2 inhibitor
Gamma-phospholipase A2 inhibitor (γ-PLI) expression profile analysis by qPCR reveals an
up-regulation around 30-fold in adults in relation to juvenile specimens (Fig. 1B). From
our cDNA library, it was possible to deduce the whole inhibitor amino acid sequence
(Fig. 3). When aligned to the sequence of a previously reported B. jararaca γ-PLI, the two
sequences differ only by four amino acids residues in the positions 48 (G→A), 200 (F→I),
201 (K→R) and 203 (T→A). Note that the amino acid position numbers correspond to
the alignment of several γ-PLI displayed in Fig. 3, which showed a high degree of similarity.
It is interesting to observe the high incidence of amino acid substitutions found in the
C-terminal region, not only between the two γ-PLI described in B. jararaca, but among
the nine inhibitors aligned, described in three different genera of snakes from Viperidae
(Bothrops and Protobothrops) and Colubridae families (Elaphe).
Inter-alpha inhibitor
Transcripts related to the serine protease inhibitor inter-alpha inhibitor presented a 5-fold
up-regulation in the liver of adult B. jararaca snakes (Fig. 1C). The partial amino acid
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Figure 3 Multiple alignments of amino acid sequences of γ- phospholipase A2 inhibitor (Bj405)
with similar sequences described in different species of snakes. The sequences used are from Bothrops
jararaca (gb|ABV91331.1), Protobothrops elegans (dbj|BAJ14719.1), Bothrops jararacussu (gb|ABV91333.1),
Bothrops alternatus (gb|ABV91326.1), Bothrops moojeni (gb|ABV91334.1), Elaphe climacophora
(dbj|BAH47550.1), Bothrops neuwiedi (gb|ABV91336.1) and Bothrops erythromelas (gb|ABV91328.1).
Identical residues are black boxed.
sequence of inter-alpha inhibitor heavy chain (H3-like) was deduced from a nucleotide
sequence found in our cDNA library, and by our knowledge this is the first description
of this molecule in B. jararaca. The inter-alpha inhibitor sequence showed similarity to
the protein described in several reptile species, such as non-venomous and venomous
snakes (Python bivittatus and Protobothrops mucrosquamatus, respectively), lizards (Anolis
carolinensis and Gekko japonicus) and turtles (Pelodiscus sinensis and Chrysemys picta bellii)
(Fig. 4).
Plasma protease C1 inhibitor
Transcripts encoding to plasma protease C1 inhibitor showed a 3-fold increased expression
in the liver of adult B. jararaca in comparison to juvenile individuals (Fig. 1D). This is the
first report on the presence of transcripts related to C1-inhibitor in B. jararaca liver. The
C1-inhibitor C-terminal deduced amino acid sequence showed some degree of similarity to
the molecule described in the lizard Anolis carolinensis, the alligator Alligator mississipiensis
and in three different species of snakes belonging to Pythonidae, Colubridae and Viperidae
families (Python bivittatus,Thamnophis sirtalis andProtobothropsmucrosquamatus) (Fig. 5).
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Figure 4 Multiple alignments of amino acid sequences of inter-alpha-trypsin inhibitor (Bj203) with
similar sequences described in different species of reptiles. The sequences used are from Gekko japonicus
(XP_015262960.1), Anolis carolinensis (XP_003217700.2), Python bivittatus (XP_007442992.1), Protoboth-
rops mucrosquamatus (XP_015671353.1), Pelodiscus sinensis (XP_006127649.1) and from Chrysemys picta
bellii (XP_008177427.1). Identical residues are black boxed.
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Figure 5 Multiple alignments of amino acid sequences of plasma protease C1 inhibitor (Bj84) with
similar sequences described in different species of reptiles. The sequences used are from Anolis caroli-
nensis (XP_008109235.1), Python bivittatus (XP_007423129.1), Thamnophis sirtalis (XP_013930568.1),
Protobothrops mucrosquamatus (XP_015676034.1) and Alligator mississippiensis (gb|KYO40723.1). Identi-
cal residues are black boxed.
When these sequences were aligned, the high variability in amino acid composition in the
C-terminal region of C1-inhibitor among the species above mentioned is remarkable, as
shown in Fig. 5.
DISCUSSION
Although a number of snake venom gland transcriptomes have been characterized and
are accessible in databases (for review, see Brahma et al., 2015) studies concerning gene
expression in other tissues are scarce and only recently became available (Castoe et al.,
2011; Schwartz et al., 2010). However, none of these studies focused on the quantitative
analysis of inhibitors that might be involved on venom neutralization, with comparison of
adult and juvenile profile. This comparative analysis may contribute to the elucidation of
the physiology and anti-venom mechanisms described in B. jararaca plasma.
Snake venom metalloproteinases (SVMPs) are the most abundant components in adult
and juvenile B. jararaca venom proteome and venom gland transcriptome (Zelanis et al.,
2012; Zelanis et al., 2016), which displays hemorrhagic activity, as described for jararhagin
(Paine et al., 1992), HF3 (Assakura, Reichl & Mandelbaum, 1986), bothropasin (Queiroz
et al., 1985) and jararafibrase (Maruyama et al., 1993). Thus, the presence of inhibitory
components in snake plasma may take part in the ‘‘accidental envenomation’’. This is the
case of the anti-hemorrhagic factor BJ46a, a glycoprotein isolated from B. jararaca plasma
that inhibits the hemorrhagic activity of its own venom, as well as the activity of isolated
metalloproteinases jararhagin and atrolysin C (Valente et al., 2001).
A previous study evaluating the ontogenetic changes in the plasma proteomic profile
of B. jararaca snakes showed that BJ46a is present in a higher relative abundance in the
plasma of adult specimens (De Morais-Zani et al., 2013) suggesting a positive association
with the higher hemorrhagic activity described in the venom of adult snakes (Antunes
et al., 2010). However, the results presented herein showed no significant differences in
BJ46a-like transcript levels between juvenile and adult B. jararaca snakes.
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A concern that must be pointed out is the high similarity between anti-hemorrhagic
factors (HSF from Protobothrops flavoviridis and BJ46a included) and other molecules with
no inhibitory activity, i.e., HLP from Protobothrops flavoviridis and HLP-A and HLP-B
from Gloydius brevicaudus (Aoki et al., 2009; Yamakawa & Omori-Satoh, 1992). These
molecules are classified based on their primary structures as members of the fetuin family
(Aoki et al., 2009).
The BJ46a-like transcript analyzed herein shows a high degree of similarity to BJ46a and
HLP-B. In fact, the partial deduced sequence of this transcript contains specific amino acid
residues related to BJ46a and HLP-B, as well as exclusive substitutions (Data S3). These
findings indicate that in the present work we described a new molecule, although it is not
possible to ensure its anti-hemorrhagic activity based only on its primary (and partial)
amino acid sequence.
Aoki et al. (2009) concluded that HLP-B from Gloydius brevicaudus corresponds to the
ortholog of the mammalian fetuins and that the anti-hemorrhagic factors HSF and HLP-A
possibly evolved from this molecule in order to display a protective role against its own
venom. In this context, it is possible that the new molecule describe in this work represents
this transition in B. jararaca. Nevertheless, the mechanisms underlying the regulation of
the expression of BJ46a and BJ46a-like molecules in juvenile and adult B. jararaca snakes
need to be elucidated.
Three structural classes of PLIs have been described in snake plasma: (1) α-PLIs, which
inhibit specifically acidic PLA2s from group II (found in the venom of Viperidae snakes),
(2) β-PLIs, which inhibit specifically basic PLA2s from group II, and (3) γ-PLIs, which
show inhibitory activity towards group I (from venom of Elapidae, Hydrophiidae and
Colubridae snakes) and II PLA2s (Estevao-Costa et al., 2008; Inoue et al., 1997; Kinkawa
et al., 2010). Considering the broad spectrum of pharmacological activities displayed by
snake venom PLA2s, as neurotoxicity, myotoxicity, edema-inducing and anticoagulant
activities, the presence of PLIs in the plasma of these animals is of paramount importance.
In addition to the key role of these PLIs for snake physiology, the identification and
characterization of PLIs are of great interest for biotechnological purposes, especially
those called MIPs (myotoxin inhibitor toxin), which target specifically basic Asp49- and
Lys49-PLA2s, responsible for local myonecrosis, one of the most serious consequences of B.
jararaca envenoming (Campos et al., 2016;Mora-Obando et al., 2014; Santoro et al., 2008).
In the present work, we analyzed the transcriptional profile of a γ-PLI in the liver of
juvenile and adult B. jararaca snakes. qPCR results showed that the levels of transcripts
encoding to γ-PLI was 30-fold higher in adult than those observed in juvenile specimens.
At a first glance, these are unexpected results, since a previous plasma proteomic analysis
indicated that γ-PLI are found in a higher relative abundance in the plasma of juvenile B.
jararaca (De Morais-Zani et al., 2013) and the venom of juvenile specimens also displayed
higher catalytic PLA2 activity (Antunes et al., 2010). However, a study conducted by
Kinkawa et al. (2010) showed that the gene expression of α-, β- and γ-PLIs was induced
by the intramuscular injection of venom in the venomous snake Gloydius brevicaudus.
Therefore, the higher expression levels of γ-PLI in adult B. jararaca liver described herein
might be the result of the physiological response of the snakes to the repeatedly contact with
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their own venom during their development. However, we can not discard the possibility
that this increase is under genetic control, a hypothesis that will be discussed further in
this article.
The previously reported B. jararaca γ-PLI (Estevao-Costa et al., 2008) and the γ-PLI
reported herein differ only in four of 200 amino acids (including the 19-residue signal
peptide), showing that we described for the first time a new isoform of this inhibitor.
The presence of γ-PLI isoforms was described in Lachesis muta (Fortes-Dias, Barcellos &
Estevao-Costa, 2003) and in several Bothrops species (Estevao-Costa et al., 2008). The vari-
ability in amino acid sequence and in inhibitory activity of thesemolecules is not surprising,
considering that snake venoms that contains PLA2 are often composed by a mixture of
isoforms of these enzymes (Estevao-Costa et al., 2008). Therefore, the presence of γ-PLI
isoforms in snake plasma may be of great physiological importance, ensuring the efficiency
of these molecules and broadening their range of inhibition (Estevao-Costa et al., 2008).
Besides a number of amino acid substitutions were present amongst γ-PLI described
in species from Bothrops genera, a highly conserved region composed by 15 amino acid
residues (104QPFPGLPLSRPNGYY118) is present in all of them and it was recognized as
the consensus motif most probably involved in the interaction of γ-PLI with snake venom
PLA2 (Estevao-Costa et al., 2008).
This 15-residue sequence, as well as the 16 cysteines in the mature protein and
the proline-rich region (residues 100–120 in Fig. 3), which play an important role in
maintaining the conformation of the interaction sites of the molecule (Dunn & Broady,
2001; Kini, 1998), are conserved in the molecule described herein, reinforcing its PLA2
inhibitory activity and protective role in snake plasma. The four amino acids substitutions
observed in the molecule described in the present work in the positions 48 (A→G), 200 (I
→F), 201 (R→K) and 203 (A→T) (the last two also described in γ-PLI of E. climacophora),
may exert little or no influence in its inhibitory activity, since these residues are not identified
(to date) as key residues for the biological activity of the molecule.
Snake venom serine proteinases (SVSPs) are another important group of toxins that play
a central role in the envenomation caused by B. jararaca snake. These enzymes affect mainly
the hemostatic system, acting on the components of the coagulation cascade and on the fib-
rinolytic and kallilrein-kinin systems (Serrano, 2013). In terms of relative abundance, SVSPs
occupy the second position in the venom proteome of this species (Zelanis et al., 2016). Due
to the central activity displayed by these toxins, we selected two serine proteinase inhibitors
to evaluate the level of their related transcripts in juvenile and adult B. jararaca snakes.
Inter-alpha inhibitors constitute a family of proteins that acts in the regulation of
the inflammatory process and plays a role in wound healing (Kobayashi, 2006; Lim,
2013). These molecules broadly inhibit serine proteases, decrease pro-inflammatory and
enhance anti-inflammatory mediators and block complement activation during systemic
inflammation (Fries & Kaczmarczyk, 2003; Okroj et al., 2012). These inhibitors can be
found in plasma as inter alpha inhibitor, which is composed by two heavy chains (H1 and
H2) and one light chain (LC), or as pre-alpha inhibitor, which consists of one heavy (H3)
and one light chain (LC) (Fries & Blom, 2000). In this work, we found that transcripts
related to the heavy chain of pre-alpha inhibitor (H3-like) presented a 5-fold up-regulation
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in the liver of adult B. jararaca snakes. It seems plausible that this inhibitor can play a role
on the neutralization of the major and minor activities of SVSP, such as disturbance of
hemostasis and induction of inflammatory reactions, respectively.
Another important plasma serine proteinase inhibitor is C1 inhibitor, a multi-functional
molecule that acts inactivating a number of serine proteases in different enzymatic
cascades, as complement, coagulation, and fibrinolytic systems (Ghannam et al., 2016).
It was hypothesized that this inhibitor could be involved in the neutralization of venom
components in case of accidental envenomation. In addition to the impact on blood coag-
ulation, B. jararaca SVSP can activate the complement system and, consequently, generate
anaphylatoxins that might play a key role in the inflammatory process and also contribute
to the spreading of other venom toxins (Pidde-Queiroz et al., 2010). Therefore, we decided
to evaluate the levels of transcripts related to C1 inhibitor in the liver of B. jararaca snakes.
Results described herein showed that transcripts encoding to this plasma inhibitor showed
a 3-fold increase in the liver of adult specimens in comparison to juvenile individuals.
The analysis of ontogenetic variation in venom activities of B. jararaca showed that the
activity of serine proteinases is slightly higher in adult individuals (Antunes et al., 2010),
which could justify the higher expression of serine proteinase inhibitors, as inter-alpha
inhibitor and C1 inhibitor, found in the liver of adult snakes.
Besides the possible role in neutralization of venom components, plasmatic serine
proteinase inhibitors play a fundamental role in hemostasis maintenance in reptiles.
Reptiles have armored skin, low blood pressure, slow circulation time, and are commonly
lethargic in their movements. Therefore, their arterial blood moves in conditions more
like those of the mammal venous side, which would favor the occurrence of intravascular
clotting (Tanaka-Azevedo, Tanaka & Sano-Martins, 2003). Nevertheless, blood coagulation
in reptiles is slower than in mammals, due to the absence or low concentration of
some coagulation factors (such as VIII and IX) (Didisheim, Hattori & Lewis, 1959) and
the presence of specific inhibitors (Morais et al., 2009; Tanaka-Azevedo, Tanaka & Sano-
Martins, 2003; Tanaka-Azevedo et al., 2004).
However, it is noteworthy that 3 out of 4mRNA related to the plasmatic proteins studied
in the present work are more expressed in the liver of adult snakes. Bearing in mind the
results described by Kinkawa et al. (2010), regarding the control of PLIs expression, and
taken together the results presented in herein, it is tempting to suggest that the higher
expression levels of γ-PLI, inter-alpha inhibitor and C1-inhibitor observed in adult snakes
might be a natural physiological response of the snakes to the recurrent contact with their
own venom throughout the life.
Nevertheless, venom neutralizing factors are identified in the serum of neonates of
the ophiophagus snake Clelia clelia, before any contact with venom during feeding on
venomous snakes. This observation shows that, at least for this species, the contact with
venoms is not the driving factor for the expression of plasmatic molecules with antivenom
properties, being under genetic control. In this context, another possibility to be considered
is that the expression of transcripts related to protease inhibitors in B. jararaca is under a
genetically programmed control, being predetermined to be highly expressed in the adult
stage. Indeed, bites between snakes are more prone to happen among adult individuals,
Gomes et al. (2017), PeerJ, DOI 10.7717/peerj.3203 12/19
especially during the period of copulation, when the encounter and contact between snakes
are more frequent (SS Sant’Anna, pers. comm., 2017). Nevertheless, these conclusions are
speculative and it is important to emphasize that complementary studies are necessary to
support these hypotheses.
In summary, this work provides the first comparative analysis of ontogenetic variation
of expression profiles of plasmatic proteins with potential anti-venom activities of the
venomous snake B. jararaca. Our data contributes to the understanding of the natural
resistance against ‘‘self-envenomation’’ described in these snakes and provide new target
molecules with biotechnological potential that can be useful for the development of new
approaches for the treatment of ophidic accidents.
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